Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dachuang Zhou

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Infectious Agents and Cancer|April 18, 2025
Cost-benefit analysis of p16<sup>INK4a</sup> immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in ChinaDachuang Zhou, Jun Hou, Jiayi Xi, et al.
BMC Medicine|January 11, 2024
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancerHanqiao Shao, Mingye Zhao, Ai-Jia Guan, et al.
BMC Health Services Research|October 1, 2025
Cost-benefit analysis of universal screening for HCV infection in China: a Markov modelling studyDachuang Zhou, Liangxiu Xu, Yimei Zhong, et al.
Vaccines|December 24, 2025
Disease and Economic Burden Averted by Hib Vaccination in 160 Countries: A Machine-Learning AnalysisDachuang Zhou, Siyang Chan, Yimei Zhong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Infectious Agents and Cancer|April 18, 2025
Cost-benefit analysis of p16<sup>INK4a</sup> immunocytology and liquid-based cytology triage after primary HPV testing for cervical cancer screening in ChinaDachuang Zhou, Jun Hou, Jiayi Xi, et al.
BMC Medicine|January 11, 2024
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancerHanqiao Shao, Mingye Zhao, Ai-Jia Guan, et al.
BMC Health Services Research|October 1, 2025
Cost-benefit analysis of universal screening for HCV infection in China: a Markov modelling studyDachuang Zhou, Liangxiu Xu, Yimei Zhong, et al.
Vaccines|December 24, 2025
Disease and Economic Burden Averted by Hib Vaccination in 160 Countries: A Machine-Learning AnalysisDachuang Zhou, Siyang Chan, Yimei Zhong, et al.
Pageof 2